PTPN11 is an oncogene involved in the MAPKinase pathway and is mutated in 23–56.7% of HS cases, mainly in two hotspots (E76K or G503V), depending on clinical presentation25–27. Here, PTPN11 is linked to histiocytic sarcoma.